ArticleOncoTargets and therapy2012

Axitinib for the treatment of patients with advanced metastatic renal cell carcinoma (mRCC) after failure of prior systemic treatment.

Viktor Grünwald et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.